Patents, access to medicines and the role of non-governmental organisations

Journal of Generic Medicines

Volumn 1, Issue 2, 2004, Pages 137-145

  Ford, Nathan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; ESSENTIAL DRUG; FLUCONAZOLE; GENERIC DRUG; ZIDOVUDINE;

ARTICLE; COST CONTROL; CRYPTOCOCCAL MENINGITIS; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; GOVERNMENT REGULATION; GUATEMALA; HEALTH CARE ACCESS; HEALTH PROMOTION; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LICENSING; ORGANIZATION; PATENT; PHARMACEUTICAL CARE; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; SOUTH AFRICA; THAILAND; WORLD HEALTH ORGANIZATION;

EID: 12344282518     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940005     Document Type: Article

References (31)

1. World Health Organization (2001) 'The World Health Report', WHO, Geneva, p. 144.
2. Pecoul, B., Chirac, P., Trouiller, P. and Pinel, J. (1999) 'Access to essential drugs in poor countries, a lost battle?', Journal of the American Medical Association, Vol. 4, pp. 361-367.
3. Goemaere, E., Ford, N. and Benatar, S. (2002) 'HIV/AIDS prevention and treatment', Lancet, Vol. 360, No. 9326, p. 86.
4. WHO/Essential Drugs and Medicines Policy (2000) 'Global comparative pharmaceutical expenditures with related reference information', Health Economics and Drugs, EDM Series No. 3 (EDM/PAR/2000.2), p. 56.
5. Lee, J. W. (2003) Speech to the Fifty-sixth World Health Assembly, Geneva, 21st May, WHO, Geneva, A56/DIV/9.
6. Médecins Sans Frontières (2003) 'ACT NOW to get malaria treatment that works to Africa', Geneva, May. Available at http://www.accessmed-msf.org/prod/ publications.asp?scntid=2442003111212&contenttype=PARA&.
7. Laing, R., Waning, B., Gray, A. et al. (2002) '25 years of the WHO essential medicines list: Progress and challenges', Lancet, Vol. 361, No. 9370, pp. 1723-1729.
8. World Trade Organization (2001) 'Doha Ministerial Declaration on the TRIPS Agreement and Public Health', para. 4, WTO Doc No WT/MIN(01)/DEC/2 (2001), WTO, Qatar.
9. See http://www.msf.org.
10. Orbinski, J. (1999) Nobel Prize acceptance speech, Oslo, December. Available at http://www.msf.org/content/ page.cfm?articleid=6589CCA6-DC2C-11D4-B2010060084A6370.
11. Galvão, J. (2002) 'Access to antiretroviral drugs in Brazil', Lancet, Vol. 360, No. 9348, p. 1862.
12. Médecins Sans Frontières (2003) 'Doha derailed: A progress report on TRIPS and access to medicines', MSF, Geneva, August. Available at http://www.accessmed-msf.org/prod/ publications.asp?scntid=27820031110385&contenttype=PARA&.
13. Scherer, F. M. and Watal, J. (2001) 'Post-TRIPS options for access to patented medicines in developing countries', Commission on Macroeconomics and Health, Working Paper Series, Paper No. WG4:1, June, pp. 15-16.
14. 't Hoen, E. (2002) 'TRIPS, pharmaceutical patents and access to essential medicines: A long way from Seattle to Doha', Chicago Journal of International Law, 24th June.
15. Pharmaceutical Manufacturers' Association of South Africa v President of the Republic of South Africa (1998), Case No. 4183/98 (filed 18th February).
16. Barber, S. (1998) 'US withholds benefits over Zuma's Bill', Business Day, Vol. 13, 15th July.
17. Letter from Sir Leon Brittan to Vice President T. M. M'Beki, 23rd March 1998. Available at http://www.cptech.org/ip/health/eu/brittan.html.
18. Sidley, P. (2001) 'Silent trump card gives state winning hand', Business Day, 20th April.
19. von Schoen Angerer, T., Wilson, D., Ford, N. and Kasper T. (2001) 'Access and activism: The provision of antiretroviral therapy in developing countries', AIDS, Vol. 15 (Suppl. 4), pp. S81-S90.
20. Terreblanche, C. (2003) 'Finally... a 'yes' from government's Dr No', Cape Times, 8th August, 2003.
21. Wilson. D., Cawthorne, P., Ford, N. and Aongsonwang, S. (1999) 'Global trade and access to medicines: AIDS treatment in Thailand', Lancet, Vol. 354, No. 9193, pp. 1893-1895.
22. Limpananont, J. (2002) 'Thailand: The impact of pressure from the US. Patents, pills and public health: Can TRIPS deliver?', Panos, London, pp. 41-43.
23. Ahmad, K. (2002) 'Thailand court forces reversal of drug firm antiretroviral patent', Lancet, Vol. 360, No. 9341, p. 1230.
24. Siringi, S. (2001) 'Generic drugs battle moves from South Africa to Kenya', Lancet, Vol. 357, No. 9268, p. 1598.
25. Anon. (2001) 'Kenya readies Aids drugs law', BBC, 22nd April. Available at http://news.bbc.co.uk/1/hi/world/africa/1291200.stm.
26. Anon. (2003) 'Kenya to make Aids drugs', BBC, 23rd September. Available at http://news.bbc.co.uk/2/hi/africa/3123008.stm.
27. Kristoff, N. (2003) 'Death by dividend', New York Times, 22nd November.
28. Anon. (2003) 'Guatemala: New congressional decree hinders access to medicines', MSF, Guatemala City, 10th July. Available at http://www.accessmed-msf.org/prod/ publications.asp?scntid=1072003163637&contenttype=PARA&.
29. Médecins Sans Frontières (2003) 'Trading health away: Intellectual property and access to medicines in the Free Trade Area of the America's (FTAA) Agreement', New York, September. Available at: http://www.doctorswithoutborders.org/pubhcations/reports/2003/ FTAA_Advocacy.pdf.
30. Médecins Sans Frontières (2003) 'Reneging on Doha: An MSF analysis of recent attempts to restrict developing countries' use of compulsory licensing to a set list of diseases', Geneva, 13th May. Available at http://www.accessmedmsf.org/prod/ publications.asp?scntid=13520031546543&contenttype=PARA&.
31. Pollock, A. and Price, D. (2003) 'New deal from the World Trade Organization', British Medical Journal, Vol. 327, pp. 571-572.